Medicare Enrolled
Dr. Michael Attanasio, D.O.
Family Medicine · Philadelphia, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Attanasio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Attanasio?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Attanasio
Dr. Michael Attanasio is a family medicine specialist in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Attanasio performed 2,124 Medicare services across 1,238 unique beneficiaries.
Between the years covered by Open Payments, Dr. Attanasio received a total of $228,354 from 76 pharmaceutical and/or device companies across 1755 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Attanasio is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in PA
$228,354 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,124
Medicare services
Top 7% in PA for family medicine
1,238
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~106 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
739 | $61 | $120 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
424 | $49 | $205 |
| Annual alcohol misuse screening, 5 to 15 minutes | 214 | $20 | $25 |
| Annual depression screening | 208 | $20 | $30 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
186 | $33 | $201 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
166 | $45 | $145 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
127 | $86 | $145 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
16 | $152 | $250 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
16 | $90 | $350 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
15 | $67 | $250 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
13 | $11 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$228,354
Total received (2018-2024)
Avg $32,622/year across 7 years
Top 0% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
1,755
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$151,392 (66.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$57,324 (25.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,638 (8.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$25,238
2023
$62,220
2022
$42,402
2021
$29,384
2020
$22,474
2019
$14,101
2018
$32,535
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$12,316
Janssen Pharmaceuticals, Inc
$5,027
ABBVIE INC.
$4,835
AstraZeneca Pharmaceuticals LP
$518
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$379
Novartis Pharmaceuticals Corporation
$285
Bayer Healthcare Pharmaceuticals Inc.
$235
Boehringer Ingelheim Pharmaceuticals, Inc.
$229
Lilly USA, LLC
$194
GlaxoSmithKline, LLC.
$180
Novo Nordisk Inc
$144
Takeda Pharmaceuticals U.S.A., Inc.
$112
Xeris Pharmaceuticals, Inc.
$94
SHIELD THERAPEUTICS INC
$88
Exact Sciences Corporation
$66
Ardelyx, Inc.
$58
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$50
Kowa Pharmaceuticals America, Inc.
$49
Phathom Pharmaceuticals, Inc.
$43
Corcept Therapeutics
$43
Collegium Pharmaceutical, Inc.
$35
PFIZER INC.
$34
Esperion Therapeutics, Inc.
$33
Agios Pharmaceuticals, Inc.
$29
E.R. Squibb & Sons, L.L.C.
$28
Astellas Pharma US Inc
$25
Abbott Laboratories
$24
Phadia US Inc.
$22
Merck Sharp & Dohme LLC
$22
Inari Medical, Inc.
$17
Vanda Pharmaceuticals Inc.
$16
TheracosBio, LLC
$8
Top 3 companies account for 87.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$115,610
Amgen Inc.
$59,008
AbbVie Inc.
$11,281
ABBVIE INC.
$7,063
Allergan, Inc.
$6,994
Allergan Inc.
$5,729
AstraZeneca Pharmaceuticals LP
$3,260
Novo Nordisk Inc
$3,014
Eli Lilly and Company
$2,250
GlaxoSmithKline, LLC.
$1,868
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,582
Lilly USA, LLC
$1,413
Novartis Pharmaceuticals Corporation
$918
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$693
Astellas Pharma US Inc
$620
Bayer Healthcare Pharmaceuticals Inc.
$563
Amarin Pharma Inc.
$529
Takeda Pharmaceuticals U.S.A., Inc.
$491
Kowa Pharmaceuticals America, Inc.
$453
PFIZER INC.
$445
Merck Sharp & Dohme Corporation
$437
Esperion Therapeutics, Inc.
$336
Bayer HealthCare Pharmaceuticals Inc.
$297
Merck Sharp & Dohme LLC
$204
Eisai Inc.
$201
IDORSIA PHARMACEUTICALS US INC
$178
ITI, Inc.
$177
Exact Sciences Corporation
$162
SANOFI-AVENTIS U.S. LLC
$156
Collegium Pharmaceutical, Inc.
$133
Teva Pharmaceuticals USA, Inc.
$131
Medtronic MiniMed, Inc.
$130
Corcept Therapeutics
$122
Abbott Laboratories
$103
Bio Products Laboratory USA, Inc.
$98
Xeris Pharmaceuticals, Inc.
$94
SHIELD THERAPEUTICS INC
$88
Almatica Pharma LLC
$85
Daiichi Sankyo Inc.
$82
E.R. Squibb & Sons, L.L.C.
$81
Sunovion Pharmaceuticals Inc.
$79
Bausch Health US, LLC
$77
Horizon Therapeutics plc
$76
Otsuka America Pharmaceutical, Inc.
$75
Neurocrine Biosciences, Inc.
$74
AbbVie, Inc.
$67
Medtronic, Inc.
$63
Circassia Pharmaceuticals Inc
$61
Shield Therapeutics Inc
$60
Ardelyx, Inc.
$58
Phathom Pharmaceuticals, Inc.
$57
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$50
IRONWOOD PHARMACEUTICALS, INC
$45
Phadia US Inc.
$34
Paratek Pharmaceuticals, Inc.
$32
Agios Pharmaceuticals, Inc.
$29
Gilead Sciences, Inc.
$26
Sanofi Pasteur Inc.
$25
Biohaven Pharmaceuticals, Inc.
$24
Genentech USA, Inc.
$20
EISAI INC.
$20
LINUS HEALTH, INC.
$19
West-Ward Pharmaceuticals
$17
Inari Medical, Inc.
$17
BioDelivery Sciences International, Inc.
$16
SANOFI PASTEUR INC.
$16
Vanda Pharmaceuticals Inc.
$16
Philips Electronics North America Corporation
$16
Scilex Pharmaceuticals Inc.
$15
ARBOR PHARMACEUTICALS, INC.
$15
Galderma Laboratories, L.P.
$15
RedHill Biopharma Inc.
$15
Inspire Medical Systems, Inc.
$13
Purdue Pharma L.P.
$13
Zyla Life Sciences, Inc.
$11
TheracosBio, LLC
$8
Top 3 companies account for 81.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADACEL · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APLENZIN · ASMANEX · Aimovig · AirDuo Digihaler · Amitiza · ArmonAir Digihaler · BELBUCA · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · Belbuca · Brenzavvy · CAMZYOS · CAPLYTA · CHANTIX · COLOGUARD · COMIRNATY · CORE COGNITIVE EVALUATION · CREON · Cologuard Collection Kit · Creon · DIFICID · DUEXIS · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FANAPT · FARXIGA · FASENRA · FLOWTRIEVER CATHETER · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GRALISE · GUARDIAN CONNECT · GVOKE HYPOPEN · Gammaplex · IBSRELA · INGREZZA · INJECTAFER · INPEN SMART INSULIN DELIVERY SYSTEM · INSPIRE · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LIVALO · LOKELMA · LONHALA MAGNAIR · LOREEV XR · LYRICA · Levemir · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Minimed 670G System · Mitigare · Morphabond ER · Movantik · Myrbetriq · NEXLETOL · NEXLIZET · NO PRODUCT DISCUSSED · NURTEC ODT · NUZYRA · Neuromodulation Dspsbls and Accs · OFEV · Otezla · Ozempic · PENNSAID · PIFELTRO · PREMARIN · PREVNAR - 13 · PYRUKYND · Prolia · QULIPTA · QUVIVIQ · RELISTOR · REXULTI · RYBELSUS · Repatha · Rybelsus · S · SEGLENTIS · SHINGRIX · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · SPRIX · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · SYNTHROID · Saxenda · Seglentis · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · UBRELVY · VERQUVO · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XTAMPZA · Xofluza · ZEPBOUND · ZORYVE · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · iPro2 · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (66%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in family medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for family medicine in PA.
Geographic Context
Family medicine physicians within 10 mi
2,435
Per 100K population
153.9
County median income
$60,698
Nearest hospital
MALVERN BEHAVIORAL HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Attanasio is a clinical cardiology specialist, with above-average Medicare volume (top 7% in PA), with speaking/promotional industry engagement in the top 0% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Attanasio experienced with nursing facility visit, low complexity?
Based on Medicare claims data, Dr. Attanasio performed 739 nursing facility visit, low complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Attanasio receive payments from pharmaceutical companies?
Yes. Dr. Attanasio received a total of $228,354 from 76 companies across 1,755 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Attanasio's costs compare to other family medicine physicians in Philadelphia?
Dr. Attanasio's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Attanasio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Philadelphia
Browse family medicine physicians in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in PA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in PA
Which PA family medicine physicians receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology